IMMUNOPHERESIS Trademark

Trademark Overview

On Friday, September 21, 2018, a trademark application was filed for IMMUNOPHERESIS with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPHERESIS trademark a serial number of 88127544. The federal status of this trademark filing is REGISTERED as of Tuesday, May 25, 2021. This trademark is owned by IMMUNICOM INC.. The IMMUNOPHERESIS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

research in the field of immunology, immunotherapy, and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases

medical devices for performing immunotherapy and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases

General Information

Serial Number88127544
Word MarkIMMUNOPHERESIS
Filing DateFriday, September 21, 2018
Status700 - REGISTERED
Status DateTuesday, May 25, 2021
Registration Number6366355
Registration DateTuesday, May 25, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesresearch in the field of immunology, immunotherapy, and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases
Goods and Servicesmedical devices for performing immunotherapy and blood filtering for medical purposes including treatment of cancer, inflammatory diseases, and autoimmune diseases
Certificate of Correction for RegistrationIn the statement, line 1, "California" should be deleted, and "Delaware" should be inserted.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code010
First Use Anywhere DateThursday, January 31, 2019
First Use In Commerce DateThursday, January 31, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code042
First Use Anywhere DateThursday, January 31, 2019
First Use In Commerce DateThursday, January 31, 2019

Trademark Owner History

Party NameIMMUNICOM INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US
Party NameIMMUNICOM INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events

Event DateEvent Description
Tuesday, September 25, 2018NEW APPLICATION ENTERED
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Thursday, January 10, 2019NON-FINAL ACTION WRITTEN
Thursday, January 10, 2019NON-FINAL ACTION E-MAILED
Thursday, January 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, July 14, 2019ASSIGNED TO LIE
Tuesday, July 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 8, 2019NON-FINAL ACTION WRITTEN
Thursday, August 8, 2019NON-FINAL ACTION E-MAILED
Thursday, August 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 7, 2020TEAS AMENDMENT OF USE RECEIVED
Saturday, February 8, 2020USE AMENDMENT FILED
Saturday, February 8, 2020AMENDMENT TO USE PROCESSING COMPLETE
Friday, February 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 16, 2020USE AMENDMENT ACCEPTED
Monday, March 16, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, September 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 13, 2020FINAL REFUSAL WRITTEN
Tuesday, October 13, 2020FINAL REFUSAL E-MAILED
Tuesday, October 13, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, April 3, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 12, 2021APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Wednesday, April 21, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 25, 2021REGISTERED-SUPPLEMENTAL REGISTER
Friday, September 17, 2021TEAS SECTION 7 REQUEST RECEIVED
Saturday, January 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, January 23, 2022CORRECTION UNDER SECTION 7 - PROCESSED
Monday, May 25, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

immunopheresis diseases medical treatment cancer inflammatory autoimmune including purposes blood immunotherapy